Hamid Reza Rasekh

[ 1 ] - The Availability and Affordability of Cardiovascular Medicines for secondary prevention in Tehran Province

Abstract Abstract Background: Availability and affordability of medicines are crucial to achieving success in prevention programs, particularly in developing countries. Objective: The aim of this study was to determine the availability and affordability of cardiovascular medicines for secondary prevention in Tehran province of Iran. Methods: A cross-sectional survey was conducted in Tehran pro...

[ 2 ] - Monetary value of quality-adjusted life years (QALY) among patients with cardiovascular disease: a willingness to pay study

The aim of this study was to estimate monetary value of a QALY among heart disease patients and to identify its determinants.A cross-sectional survey with face-to-face interview was conducted with 196 cardiovascular disease patients from two heart hospitals in Tehran, Iran, to estimate the value of QALY using disaggregated and aggregated approaches. The Euro Qol -5d (EQ-5D) questionnaire, visua...

[ 3 ] - New Product Development in the Pharmaceutical Industry: Evidence from Iran

In today’s competitive world, there are several strategies to deal with the fast changing environment, among which New product development (NPD) is a common strategy. However, almost half of the resources that companies devote to NPD are spent on products that may fail. This issue is particularly highlighted in the pharmaceutical industry mainly because of a long development-time, low success r...

[ 4 ] - Cost-Effectiveness Analysis of Biogeneric Recombinant Activated Factor VII (AryoSeven™) and Activated Prothrombin Complex Concentrates (FEIBA™) to Treat Hemophilia A Patients with Inhibitors in Iran

Abstract Nowadays, bypassing agents such as recombinant activated factor VII (rFVIIa) and activated prothrombin complex concentrates (aPCC) are used to treat bleeding episodes in the Hemophilia patients with inhibitors. AryoSeven® is an Iranian biogeneric rFVIIa with homogeneity of efficacy and the nature to NovoSeven in a comparative trial. The current clinical trial aimed to evaluate the cost...

[ 5 ] - Administrative Process and Criteria Ranking for Drug Entering Health Insurance List in Iran-TOPSIS-Based Consensus Model

The purposes of our study were to identify a drug entry process, collect, and prioritize criteria for selecting drugs for the list of basic health insurance commitments to prepare an “evidence based reimbursement eligibility plan” in Iran.The 128 noticeable criteria were found when studying the health insurance systems of developed countries. Four parts (involving criteria) formed the first que...

[ 6 ] - Selecting the acceptance criteria of medicines in the reimbursement list of public health insurance of Iran, using the “Borda”method: a pilot study

Decision-making for medicines to be accepted in Iran’s public health insurance reimbursement list is a complex process and involves factors, which should be considered in applying a coverage for medicine costs. These processes and factors are not wholly assessed, while assessment of these factors is an essential need for getting a transparent and evidence-based approach toward medicine reimburs...

[ 7 ] - Applying a Simple Model of Cost Effectiveness Study of HPV Vaccine for Iran

HPV vaccine has been recently added to the Iran Drug List, so decision makers need information beyond that available from RCTs to recommend funding for this vaccination. Modeling and economic studies have addressed some of those information needs. We reviewed cost effectiveness studies to find a suitable model for Iranian population to determine the potential cost effectiveness of HPV vaccine p...

[ 8 ] - An Analysis of Job Satisfaction among Iranian Pharmacists through various Job Characteristics

Introduction: Pharmacists and pharmaceutical services are among the most important resources and programs in providing health for a society. Pharmacists as the key players in presenting health services, greatly impact on the health of a society and if they suffer low job satisfaction, their dissatisfaction may relatively threaten health in a society. This study was conducted to determine Irania...

[ 9 ] - Drug Literacy in Iran: the Experience of Using “The Single Item Health Literacy Screening (SILS) Tool”

Drug and health literacy is a key determinant of health outcomes. There are several tools to assess drug and health literacy. The objective of this article is to determine drug literacy level and its relationships with other factors using a single screening tool. A cross- sectional survey was conducted among 1104 people in Qazvin province, Iran. Based on the proportional-to-size method, partici...

[ 10 ] - Cost-Effectiveness Evaluation of Quadrivalent Human Papilloma Virus Vaccine for HPV-Related Disease in Iran

Human Papilloma Virus (HPV) vaccine recently has been added to the Iran Drug List, decision makers need information beyond that available from RCTs to recommend funding for this vaccination program to add it to the National Immunization program in Iran. Modeling and economic studies have addressed some of those information needs in foreign countries. In order to determine the long term benefit ...

[ 11 ] - Costs of treatment after renal transplantation: is it worth to pay more?

Objectives: The present study aimed to provide an estimation of the current financial burden of renal transplantation therapy for insurance organisations.Methods: An Excel-based model was developed to determine the treatment costs of current clinical practice in renal transplantation therapy (RTT). Inputs were derived from Ministry of Health and insurance organizations` database, hospital and p...

[ 12 ] - Developing a Model for Agile Supply: an Empirical Study from Iranian Pharmaceutical Supply Chain

Agility is the fundamental characteristic of a supply chain needed for survival in turbulent markets, where environmental forces create additional uncertainty resulting in higher risk in the supply chain management. In addition, agility helps providing the right product, at the right time to the consumer. The main goal of this research is therefore to promote supplier selection in pharmaceutica...

[ 13 ] - Situation Analysis of R & D Activities: An Empirical Study in Iranian Pharmaceutical Companies

As global competition intensifies, research and development (R & D) organizations need to enhance their strategic management in order to become goal-directed communities for innovation and allocate their resources consistent with their overall R & D strategy. The world pharmaceutical market has undergone fast, unprecedented, tremendous and complex changes in the last several years. The pharmace...

[ 14 ] - The Availability and Affordability of Cardiovascular Medicines for secondary prevention in Tehran Province

Abstract Abstract Background: Availability and affordability of medicines are crucial to achieving success in prevention programs, particularly in developing countries. Objective: The aim of this study was to determine the availability and affordability of cardiovascular medicines for secondary prevention in Tehran province of Iran. Methods: A cross-sectional survey was conducted in Tehran pro...

[ 15 ] - Monetary value of quality-adjusted life years (QALY) among patients with cardiovascular disease: a willingness to pay study

The aim of this study was to estimate monetary value of a QALY among heart disease patients and to identify its determinants.A cross-sectional survey with face-to-face interview was conducted with 196 cardiovascular disease patients from two heart hospitals in Tehran, Iran, to estimate the value of QALY using disaggregated and aggregated approaches. The Euro Qol -5d (EQ-5D) questionnaire, visua...

[ 16 ] - New Product Development in the Pharmaceutical Industry: Evidence from Iran

In today’s competitive world, there are several strategies to deal with the fast changing environment, among which New product development (NPD) is a common strategy. However, almost half of the resources that companies devote to NPD are spent on products that may fail. This issue is particularly highlighted in the pharmaceutical industry mainly because of a long development-time, low success r...

[ 17 ] - Cost-Effectiveness Analysis of Biogeneric Recombinant Activated Factor VII (AryoSeven™) and Activated Prothrombin Complex Concentrates (FEIBA™) to Treat Hemophilia A Patients with Inhibitors in Iran

Abstract Nowadays, bypassing agents such as recombinant activated factor VII (rFVIIa) and activated prothrombin complex concentrates (aPCC) are used to treat bleeding episodes in the Hemophilia patients with inhibitors. AryoSeven® is an Iranian biogeneric rFVIIa with homogeneity of efficacy and the nature to NovoSeven in a comparative trial. The current clinical trial aimed to evaluate the cost...

[ 18 ] - Administrative Process and Criteria Ranking for Drug Entering Health Insurance List in Iran-TOPSIS-Based Consensus Model

The purposes of our study were to identify a drug entry process, collect, and prioritize criteria for selecting drugs for the list of basic health insurance commitments to prepare an “evidence based reimbursement eligibility plan” in Iran.The 128 noticeable criteria were found when studying the health insurance systems of developed countries. Four parts (involving criteria) formed the first que...

[ 19 ] - Selecting the acceptance criteria of medicines in the reimbursement list of public health insurance of Iran, using the “Borda”method: a pilot study

Decision-making for medicines to be accepted in Iran’s public health insurance reimbursement list is a complex process and involves factors, which should be considered in applying a coverage for medicine costs. These processes and factors are not wholly assessed, while assessment of these factors is an essential need for getting a transparent and evidence-based approach toward medicine reimburs...

[ 20 ] - Applying a Simple Model of Cost Effectiveness Study of HPV Vaccine for Iran

HPV vaccine has been recently added to the Iran Drug List, so decision makers need information beyond that available from RCTs to recommend funding for this vaccination. Modeling and economic studies have addressed some of those information needs. We reviewed cost effectiveness studies to find a suitable model for Iranian population to determine the potential cost effectiveness of HPV vaccine p...

[ 21 ] - An Analysis of Job Satisfaction among Iranian Pharmacists through various Job Characteristics

Introduction: Pharmacists and pharmaceutical services are among the most important resources and programs in providing health for a society. Pharmacists as the key players in presenting health services, greatly impact on the health of a society and if they suffer low job satisfaction, their dissatisfaction may relatively threaten health in a society. This study was conducted to determine Irania...

[ 22 ] - Drug Literacy in Iran: the Experience of Using “The Single Item Health Literacy Screening (SILS) Tool”

Drug and health literacy is a key determinant of health outcomes. There are several tools to assess drug and health literacy. The objective of this article is to determine drug literacy level and its relationships with other factors using a single screening tool. A cross- sectional survey was conducted among 1104 people in Qazvin province, Iran. Based on the proportional-to-size method, partici...

[ 23 ] - Cost-Effectiveness Evaluation of Quadrivalent Human Papilloma Virus Vaccine for HPV-Related Disease in Iran

Human Papilloma Virus (HPV) vaccine recently has been added to the Iran Drug List, decision makers need information beyond that available from RCTs to recommend funding for this vaccination program to add it to the National Immunization program in Iran. Modeling and economic studies have addressed some of those information needs in foreign countries. In order to determine the long term benefit ...

[ 24 ] - Costs of treatment after renal transplantation: is it worth to pay more?

Objectives: The present study aimed to provide an estimation of the current financial burden of renal transplantation therapy for insurance organisations.Methods: An Excel-based model was developed to determine the treatment costs of current clinical practice in renal transplantation therapy (RTT). Inputs were derived from Ministry of Health and insurance organizations` database, hospital and p...

[ 25 ] - Developing a Model for Agile Supply: an Empirical Study from Iranian Pharmaceutical Supply Chain

Agility is the fundamental characteristic of a supply chain needed for survival in turbulent markets, where environmental forces create additional uncertainty resulting in higher risk in the supply chain management. In addition, agility helps providing the right product, at the right time to the consumer. The main goal of this research is therefore to promote supplier selection in pharmaceutica...

[ 26 ] - Situation Analysis of R & D Activities: An Empirical Study in Iranian Pharmaceutical Companies

As global competition intensifies, research and development (R & D) organizations need to enhance their strategic management in order to become goal-directed communities for innovation and allocate their resources consistent with their overall R & D strategy. The world pharmaceutical market has undergone fast, unprecedented, tremendous and complex changes in the last several years. The pharmace...

[ 27 ] - بررسی اثر عصاره تام ریزوم گیاهCurcuma amada Roxb. بر التهاب ناشی از آرتریت روماتویید در موش صحرایی نر

مقدمه: بیماری‌های مفاصل از جمله آرتریت روماتویید از مشکلات ناتوان‌کننده شایع جوامع کنونی و علم پزشکی است. درمان‌های موجود علاوه ‌بر عدم اثر بخشی بالا، عوارض جانبی زیادی دارند که این امرباعث محدودیت کاربرد آن‌ها می‌شود. امروزه شاهد تمایل زیاد علم طب و دارو درمانی به سمت استفاده از درمان‌های موثرتر چون گیاهان دارویی هستیم. براساس گزارش‌های ارایه شده گیاه Curcuma amada Roxb. از خانواده Zingiberace...

[ 28 ] - بررسی پوشش بیمه‌ای دارو در ایران در مقایسه با کشورهای منتخب

Introduction: in Iran, the compilation council of drug, having an advisory role, is responsible to cover medicine costs for health insurances. Health Insurance High Council also acts as the final decision maker about the admission of new drugs. This article studies how new drugs in Iran's health insurances are covered compared with some selected countries. Methods: After collecting drug accep...

[ 29 ] - Cost Components of Treatment Protocols of Haemophilia Patients with Inhibitors using Bypassing Agents in Iran

Bypassing agents are the most commonly used medicines for the treatment of hemophilia patients with inhibitors. The aim of this study is to identify the cost components of management of bleeding vents in hemophilia patients with inhibitors in Iran. This study is a cross-sectional study using a bottom-up approach to determine the cost components of treatment of hemophilia patients with inh...

[ 30 ] - Evaluation of affordability and impoverishment effect of cardiovascular medicines in Iran

Cardiovascular disease is one of the most important causes of death in the world. There are variety of plans and strategies to treatment and prevention of CVD. Medicines have significant role to reach the goals. Ensuring Affordability of medicines is very crucial to success in these programs. The impoverishment method which focuses on the impoverishing effect of the purchasing of medicines is o...

[ 31 ] - Supply Chain Challenges in Pharmaceutical Manufacturing Companies: Using Qualitative System Dynamics Methodology

In today’s competitive market environment, pharmaceutical companies have learned that improving supply chain performance is critical to maintain competitive advantages. Forecasting, planning, procurement, financing, stock levels, and marketing strategies are some of the areas in which managers have to decide about them and balance their enter-related effects simultaneously, to achieve organizat...

[ 32 ] - Selecting reference countries in external reference based pricing: The case study of Iran

Most countries are using some kinds of pharmaceutical policies, like external reference-based pricing, to control the costs of medicines. This policy could be implemented in different ways and there is no systematic method for selecting reference countries. In this study, we tried to identify and classify the factors affecting the selection of reference countries in Iran. Delphi method was empl...

[ 33 ] - Supply Chain Challenges in Pharmaceutical Manufacturing Companies: Using Qualitative System Dynamics Methodology

In today’s competitive market environment, pharmaceutical companies have learned that improving supply chain performance is critical to maintain competitive advantages. Forecasting, planning, procurement, financing, stock levels, and marketing strategies are some of the areas in which managers have to decide about them and balance their enter-related effects simultaneously, to achieve organizat...

[ 34 ] - Using Discrete Choice Experiment to Determine Willingness to Pay for Medicine Interferon-Beta by Multiple Sclerosis Patients

This study explores the effects of Interferon-β characteristics such as country of origin, injection frequency and method, monthly cost, efficacy, and side effects on multiple-sclerosis patients’ willingness to pay. For this purpose, MS patients with a history of using Interferon-β were studied from the three major Isfahan MS centers. Choice sets were designed with a combination of attributes a...